Literature DB >> 11860548

Rhabdomyosarcoma of the uterus: report of two cases, including one of the spindle cell variant.

W Glenn McCluggage1, T F Lioe, H R McClelland, H Lamki.   

Abstract

Most uterine sarcomas fall into the category of leiomyosarcoma, endometrial stromal sarcoma, or undifferentiated sarcoma. Pure rhabdomyosarcomas are extremely rare, although a rhabdomyosarcomatous element may be present as a component of an adenosarcoma or carcinosarcoma (malignant mixed müllerian tumor). This report describes two uterine rhabdomyosarcomas in 28- and 67-year-old women. These were of spindle cell and pleomorphic types, respectively. At presentation the pleomorphic rhabdomyosaroma was stage IV, exhibiting massive pelvic and abdominal dissemination that mimicked an ovarian neoplasm. The spindle cell rhabdomyosarcoma was stage I, being confined to the uterus. Grossly, both uterine tumors had a polypoid appearance. Immunohistochemically, tumor cells were positive with the skeletal muscle markers sarcomeric actin, myoglobin, and myoD1. The patient with stage IV disease died within a short time of diagnosis and the other patient is alive and well at 2 years' follow-up. This report adds to the published literature on uterine rhabdomyosarcomas. This is the first reported uterine case of the spindle cell variant of embryonal rhabdomyosarcoma. Based on these cases and the published literature, rhabdomyosarcoma, especially the pleomorphic variant, appears to be a very aggressive neoplasm with an extremely poor prognosis. Immunohistochemical demonstration of skeletal muscle differentiation is necessary for a definitive diagnosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11860548     DOI: 10.1046/j.1525-1438.2002.01069.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

1.  Pleomorphic rhabdomyosarcoma of the uterus in a postmenopausal patient.

Authors:  Katalin Borka; Kálmán Patai; Anikó Rendek; Gábor Sobel; Ferenc Paulin
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

2.  Embryonal rhabdomyosarcoma of the cervix with focal pleomorphic areas.

Authors:  J P Houghton; W G McCluggage
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

3.  Spindle cell rhabdomyosacoma of uterus: a case study.

Authors:  Dae Woon Kim; Jung Hwan Shin; Ho Jung Lee; Young Ok Hong; Jong Eun Joo; Eun Kyung Kim
Journal:  Korean J Pathol       Date:  2013-08-26

Review 4.  Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia.

Authors:  Esther Oliva
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

5.  Epithelioid leiomyosarcoma with rhabdoid features.

Authors:  Gülnur Yorulmaz; Gülgün Erdogan; Hadice Elif Pestereli; Burhan Savas; Fatma Seyda Karaveli
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  Spindle cell rhabdomyosarcoma of the retroperitoneum: an unusual case developed in a pregnant woman but obscured by pregnancy.

Authors:  Lu Yu; Shou Jing Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

7.  Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations.

Authors:  Jennifer A Bennett; Zehra Ordulu; Robert H Young; Andre Pinto; Koen Van de Vijver; Eike Burandt; Pankhuri Wanjari; Rajeev Shah; Leanne de Kock; William D Foulkes; W Glenn McCluggage; Lauren L Ritterhouse; Esther Oliva
Journal:  Mod Pathol       Date:  2021-05-20       Impact factor: 7.842

8.  Identification of distinct molecular subtypes of uterine carcinosarcoma.

Authors:  Yang An; Haojie Wang; Jingyao Jie; Yitai Tang; Weijuan Zhang; Shaoping Ji; Xiangqian Guo
Journal:  Oncotarget       Date:  2017-02-28

9.  Management of a rare ovarian carcinosarcoma: A case report and literature review.

Authors:  Jun Fu
Journal:  Exp Ther Med       Date:  2022-07-19       Impact factor: 2.751

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.